Dr Reddys Laboratories Key Financial Ratios, Dr Reddys …

Dr Reddys Labs Consolidated June 2024 Net Sales at Rs 7,696.10 crore, up 13.88% Y-o-Y. Dr Reddys Labs Standalone June 2024 Net Sales at Rs 5,841.20 crore, up 7.43% Y-o-Y. Dr …

CouponFollow Extension

88%
OFF

Dr Reddys Laboratories Key Financial Ratios, Dr Reddys …

1 week from now

Dr Reddys Labs Consolidated June 2024 Net Sales at Rs 7,696.10 crore, up 13.88% Y-o-Y. Dr Reddys Labs Standalone June 2024 Net Sales at Rs 5,841.20 crore, up 7.43% Y-o-Y. Dr …

moneycontrol.com

71%
OFF

Dr. Reddy's Laboratories Ratios And Metrics - Stock Analysis

1 week from now

Mar 31, 2020 · 0.71%. 0.43%. 0.91%. Upgrade. Source: S&P Capital IQ. Standard template. Financial Sources. Financial ratios and metrics for Dr. Reddy's Laboratories (RDY). Includes …

stockanalysis.com

3%
OFF

Dr. Reddy's Laboratories Ltd. Financial Ratios - Trendlyne

1 week from now

4 days ago · Book Value Per Share Dr. Reddy's Laboratories Ltd. Mar-2024 Book Value Per Share is 1,453 Rs which is growth of 18.3% YoY. POSITIVE.

trendlyne.com

45%
OFF

Dr Reddys Laboratories Consolidated Key Financial Ratios, Dr …

1 week from now

Hold Dr Reddy’s Laboratories; target of Rs 1270: ICICI Securities 06.11.2024 Dr Reddys Labs Consolidated September 2024 Net Sales at Rs 8,038.20 crore, up 16.45% Y-o-Y

moneycontrol.com

3%
OFF

Dr Reddys Laboratories Key Financial Ratios, Dr Reddys …

1 week from now

Dr Reddy's hits over 3-year high as analysts remain positive, raise target post Q3 show 04.02.2019 Dr Reddy's climbs 3% even as analysts view on Q3 earnings mixed

moneycontrol.com

45%
OFF

Dr Reddys Laboratories Balance Sheet, Dr Reddys Laboratories …

1 week from now

Neutral Dr Reddys Laboratories; target of Rs 1390: Motilal Oswal. Dr Reddys Labs Consolidated September 2024 Net Sales at Rs 8,038.20 crore, up 16.45% Y-o-Y. Dr Reddys Labs …

moneycontrol.com

FAQs about Dr Reddys Laboratories Key Financial Ratios, Dr Reddys … Coupon?

What is the fiscal year of Dr Reddy's Laboratories (RDY)?

Fiscal year is Apr - Mar. Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC). Financial ratios and metrics for Dr. Reddy's Laboratories (RDY). Includes annual, quarterly and trailing numbers with full history and charts. ...

Does Dr Reddy's Laboratories Limited have internal financial controls?

ATE ON THE STANDALONE IND AS F f Section 143 of the Companies Act, 2013 (“the Act”)We have audited the internal fi nancial controls over fi nancial reporting of Dr. Reddy’s Laboratories Limited (“the Company”) as of 31 March 2019 in conjunction with our audit of the standalone Ind AS fi nancial s ...

Who is Dr Reddy's Laboratories Ltd?

Dr. Reddy's Laboratories Ltd is a leading India-based pharamceutical company which offers a portfolio of products and services, including Active Pharmaceutical Ingredients (APIs), Custom Pharmaceutical services (CPS), generics, biosimilars and differentiated formulations. ...

Does Reddy's Laboratories Limited have good corporate governance?

ulting in a decrease in borrowings.CORPORATE GOVERNANCEDr. Reddy’s Laboratories Limited (‘Dr. Reddy’s’ or ‘the company’) believes that timely disclosures, transparent accounting policies coupled with a strong and independent board go a long way in maintaining good corporate governance, preserving shareh ...

What is Dr Reddy's Laboratories (RDY) price-to-earnings ratio?

Dr. Reddy's Laboratories (NYSE:RDY) has a trailing price-to-earnings ratio of 20.28 and a forward price-to-earnings ratio of 19.89. The price/earnings-to-growth ratio is 1.84. ...